Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.
Isolated cat right ventricular papillary muscles were used to study the effects of antibodies with high affinity for ouabain and acetyl strophanthidin on myocardium exposed to these cardioactive steroids. Antibodies with average intrinsic affinity constants for ouabain and acetyl strophanthidin of the order of 10(8) M(-1) were raised in rabbits challenged by repeated injection of a conjugate of ouabain covalently linked to a poly D,L-alanyl derivative of human serum albumin. Effects were assessed in terms of time-course and extent of inotropy reversal, influence of experimentally induced ventricular failure, digitalis-antibody concentration relations, influence of digitalis-antibody complex on response to additionally added digitalis, and relation of antibody effects on digitalis-induced automaticity and contracture to reversal of inotropy. Specific antibody (but not control antibody) in 1.1-1.5-fold molar excess over cardioactive steroid concentrations blocked positive inotropic effects of ouabain and acetyl strophanthidin, and gradually reversed established contractile effects of these agents with a mean time for half-reversal of ouabain-induced inotropy of 124+/-6 (SEM) min and 37+/-3 min for half-reversal of acetyl strophanthidin-induced inotropy. Papillary muscles from cats with right ventricular failure induced by chronic pulmonary artery constriction responded similarly. Both normal and failing muscles returned to but not below levels of contractility existing before cardioactive steroid exposure, and time for half-reversal of inotropy by antibody was significantly shorter than time for half-reversal after removal of ouabain or acetyl strophanthidin by muscle bath washout alone. Presence of ouabain- or acetyl strophanthidin-antibody complex did not alter the myocardial contractile response to subsequently added cardioactive steroids. Spontaneous automaticity occurring as a toxic response to ouabain or acetyl strophanthidin in eight muscles was rapidly reversed by specific antibody at a time when positive inotropic effects were still fully manifest. Early contracture was also reversed by specific antibody. These studies provide further support for the concept that cardiac glycoside-specific antibodies are capable of reversing established cellular effects of cardioactive steroids.
D000818:Animals; D000906:Antibodies; D002297:Cardanolides / Q000494:pharmacology*; D002415:Cats; D003864:Depression, Chemical; D004071:Digitalis Glycosides / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006333:Heart Failure / Q000276:immunology*; D006352:Heart Ventricles / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D009206:Myocardium / Q000276:immunology*; D010042:Ouabain / Q000494:pharmacology*; D010210:Papillary Muscles / Q000187:drug effects / Q000276:immunology; D011651:Pulmonary Artery / Q000276:immunology / Q000503:physiopathology; D011817:Rabbits / Q000276:immunology; D012709:Serum Albumin; D013268:Stimulation, Chemical; D013314:Stress, Mechanical; D013997:Time Factors
D000906:Antibodies; D002297:Cardanolides; D004071:Digitalis Glycosides; D012709:Serum Albumin; D010042:Ouabain